Cargando…
A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2
Breast cancer is the most common type of female cancer. Reactive oxygen species (ROS) are vital in regulating signaling pathways that control cell survival and cell proliferation. Chemotherapeutic drugs such as anthracyclines induce cell death via ROS induction. Chemoresistance development is associ...
Autores principales: | Leung, Man-Hong, Tsoi, Ho, Gong, Chun, Man, Ellen PS, Zona, Stefania, Yao, Shang, Lam, Eric W.-F., Khoo, Ui-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139508/ https://www.ncbi.nlm.nih.gov/pubmed/32110852 http://dx.doi.org/10.3390/cancers12030533 |
Ejemplares similares
-
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer
por: Tsoi, Ho, et al.
Publicado: (2021) -
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2023) -
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022) -
Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals
por: Privalsky, Martin L., et al.
Publicado: (2019) -
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022)